Literature DB >> 24859780

Soluble guanylate cyclase redox state under hypoxia or hypoxia/reoxygenation in isolated monkey coronary arteries.

Masashi Tawa1, Ayman Geddawy, Takashi Shimosato, Hirotaka Iwasaki, Takeshi Imamura, Tomio Okamura.   

Abstract

Hypoxia or hypoxia/reoxygenation impairs nitric oxide (NO)-mediated relaxation through the increase in superoxide generation in monkey coronary arteries. Soluble guanylate cyclase (sGC), the target enzyme of NO, has been shown to change from the NO-sensitive reduced form to the NO-insensitive oxidized/heme-free form under substantial oxidative stress, so the present study investigated whether hypoxia or hypoxia/reoxygenation influences sGC redox equilibrium. In isolated monkey coronary arteries without endothelium, the relaxation caused by the sGC stimulator BAY 41-2272 (Emax: 93.3% ± 2.2%) was somewhat impaired under hypoxia (Emax: 86.3% ± 2.6%) or hypoxia/reoxygenation (Emax: 86.1% ± 3.2%), whereas that by the sGC activator BAY 60-2770 (Emax: 86.0% ± 3.2%) was significantly augmented under hypoxia (Emax: 94.4% ± 1.3%) or hypoxia/reoxygenation (Emax: 95.5% ± 1.1%). In addition, cGMP formation in response to BAY 41-2272 and BAY 60-2770 was inhibited and stimulated, respectively, under hypoxia or hypoxia/reoxygenation. The effects of hypoxia or hypoxia/reoxygenation on BAY 41-2272- and BAY 60-2770-induced vasorelaxation were completely canceled by the treatment with the superoxide dismutase mimetic tempol. These findings suggest that sGC redox equilibrium in the coronary artery is shifted towards the NO-insensitive form under hypoxia or hypoxia/reoxygenation and that superoxide seems to play an important role in this shift.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24859780     DOI: 10.1254/jphs.14046fp

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  5 in total

1.  Vasorelaxing effects of the soluble guanylyl cyclase activator BAY 60-2770 in nitrate-tolerant monkey and canine coronary arteries.

Authors:  Masashi Tawa; Takashi Shimosato; Hirotaka Iwasaki; Takeshi Imamura; Tomio Okamura
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-01-13       Impact factor: 3.000

2.  Effect of Shenmai injection on preventing the development of nitroglycerin-induced tolerance in rats.

Authors:  Qian Zhou; Yan Sun; Wangxiao Tan; Xiao Liu; Yuchen Qian; Xianghui Ma; Ting Wang; Xiaoying Wang; Xiumei Gao
Journal:  PLoS One       Date:  2017-04-28       Impact factor: 3.240

3.  Soluble guanylate cyclase redox state under oxidative stress conditions in isolated monkey coronary arteries.

Authors:  Masashi Tawa; Tomio Okamura
Journal:  Pharmacol Res Perspect       Date:  2016-09-16

4.  Irreversible Activation and Stabilization of Soluble Guanylate Cyclase by the Protoporphyrin IX Mimetic Cinaciguat.

Authors:  Alexander Kollau; Marissa Opelt; Gerald Wölkart; Antonius C F Gorren; Michael Russwurm; Doris Koesling; Bernd Mayer; Astrid Schrammel
Journal:  Mol Pharmacol       Date:  2017-11-14       Impact factor: 4.436

5.  Alteration of the soluble guanylate cyclase system in coronary arteries of high cholesterol diet-fed rabbits.

Authors:  Masashi Tawa; Katsuya Nakano; Yuka Yamashita; Qiang He; Takayoshi Masuoka; Tomio Okamura; Takaharu Ishibashi
Journal:  Pharmacol Res Perspect       Date:  2021-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.